Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Oct;98(2):574–580. doi: 10.1111/j.1476-5381.1989.tb12631.x

Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.

M J Parnham 1, C Bittner 1, G Lambrecht 1
PMCID: PMC1854744  PMID: 2819335

Abstract

1. The effects of the platelet activating factor (Paf) antagonists alprazolam, BN 52021, kadsurenone, L 652,731 and SRI 63119 have been studied on Paf-induced chemiluminescence (CL) of guinea-pig, C. parvum-activated peritoneal macrophages in vitro. 2. All antagonists produced a shift to the right in the dose-response curve to Paf (0.001-10 mumol l-1). Schild plots for BN 52021, L 652,731, kadsurenone and SRI 63119 were linear, but only for BN 52021 and kadsurenone did the mean slope not differ significantly from unity. Mean pA2 values for BN 52021 and kadsurenone were 6.60 +/- 0.05 and 6.41 +/- 0.14 (mean + s.e.mean) respectively. Calculation of IC50 values for all antagonists (at 0.1 mumol l-1 Paf) gave an order of potency: L 652731 greater than kadsurenone greater than or equal to BN 52021 greater than alprazolam greater than SRI 63119. 3. When individual pA2 values for BN 52021 and kadsurenone were plotted against the maximal CL response to Paf of cell suspensions in the absence of antagonist (reflecting the degree of activation of the macrophages by the C. parvum), it was found that the affinity of both antagonists for macrophage Paf receptors remained relatively constant irrespective of the activation state of the cells. 4. We conclude that activation of guinea-pig peritoneal macrophages does not account for the increased affinity for macrophage Paf receptors previously observed for kadsurenone. Kadsurenone and BN 52021 presumably bind to a site on Paf receptors which is not affected by the activation process, while alprazolam and SRI 63119 are non-specific antagonists. The reason for the difference between the competitive nature of kadsurenone and its structural analogue L 652,731 is unclear.

Full text

PDF
574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  2. Descotes J., Tedone R., Evreux J. C. Suppression of humoral and cellular immunity in normal mice by diazepam. Immunol Lett. 1982 Jul;5(1):41–42. doi: 10.1016/0165-2478(82)90089-x. [DOI] [PubMed] [Google Scholar]
  3. Handley D. A., Van Valen R. G., Saunders R. N. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. Immunopharmacology. 1986 Jun;11(3):175–182. doi: 10.1016/0162-3109(86)90019-6. [DOI] [PubMed] [Google Scholar]
  4. Hartung H. P. Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7. FEBS Lett. 1983 Aug 22;160(1-2):209–212. doi: 10.1016/0014-5793(83)80968-5. [DOI] [PubMed] [Google Scholar]
  5. Hartung H. P., Parnham M. J., Winkelmann J., Englberger W., Hadding U. Platelet activating factor (PAF) induces the oxidative burst in macrophages. Int J Immunopharmacol. 1983;5(2):115–121. doi: 10.1016/0192-0561(83)90002-4. [DOI] [PubMed] [Google Scholar]
  6. Hayashi H., Kudo I., Inoue K., Onozaki K., Tsushima S., Nomura H., Nojima S. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists. J Biochem. 1985 Jun;97(6):1737–1745. doi: 10.1093/oxfordjournals.jbchem.a135232. [DOI] [PubMed] [Google Scholar]
  7. Huang S. J., Monk P. N., Downes C. P., Whetton A. D. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. Biochem J. 1988 Feb 1;249(3):839–845. doi: 10.1042/bj2490839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hwang S. B. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem. 1988 Mar 5;263(7):3225–3233. [PubMed] [Google Scholar]
  9. Hwang S. B., Lam M. H. Species difference in the specific receptors of platelet activating factor. Biochem Pharmacol. 1986 Dec 15;35(24):4511–4518. doi: 10.1016/0006-2952(86)90772-0. [DOI] [PubMed] [Google Scholar]
  10. Kornecki E., Ehrlich Y. H., Lenox R. H. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science. 1984 Dec 21;226(4681):1454–1456. doi: 10.1126/science.6150550. [DOI] [PubMed] [Google Scholar]
  11. Lambrecht G., Parnham M. J. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes. Br J Pharmacol. 1986 Feb;87(2):287–289. doi: 10.1111/j.1476-5381.1986.tb10816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Donnell S. R., Barnett C. J. pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. Br J Pharmacol. 1988 Jun;94(2):437–442. doi: 10.1111/j.1476-5381.1988.tb11545.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Parnham M. J. PAF receptors. Prog Biochem Pharmacol. 1988;22:17–24. [PubMed] [Google Scholar]
  14. Shen T. Y., Hwang S. B., Chang M. N., Doebber T. W., Lam M. H., Wu M. S., Wang X., Han G. Q., Li R. Z. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad Sci U S A. 1985 Feb;82(3):672–676. doi: 10.1073/pnas.82.3.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stewart A. G., Dusting G. J. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol. 1988 Aug;94(4):1225–1233. doi: 10.1111/j.1476-5381.1988.tb11642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Valone F. H. Identification of platelet-activating factor receptors in P388D1 murine macrophages. J Immunol. 1988 Apr 1;140(7):2389–2394. [PubMed] [Google Scholar]
  17. Walker W. S., Beelen R. H. Macrophage cell cycling: influence of proliferative state on the antibody-mediated activities of rat resident peritoneal macrophages. Cell Immunol. 1988 Feb;111(2):492–500. doi: 10.1016/0008-8749(88)90112-8. [DOI] [PubMed] [Google Scholar]
  18. Ward S. G., Westwick J. Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. Br J Pharmacol. 1988 Apr;93(4):769–774. doi: 10.1111/j.1476-5381.1988.tb11461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zavala F., Haumont J., Lenfant M. Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol. 1984 Nov 27;106(3):561–566. doi: 10.1016/0014-2999(84)90059-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES